RT @NatureBiotech: Our 2Q19 drug pipeline Data Page includes @Novartis's #Piqray (alpelisib), the first new drug application for a new mol…
RT @NatureBiotech: Our 2Q19 drug pipeline Data Page includes @Novartis's #Piqray (alpelisib), the first new drug application for a new mol…
RT @NatureBiotech: Our 2Q19 drug pipeline Data Page includes @Novartis's #Piqray (alpelisib), the first new drug application for a new mol…
RT @NatureBiotech: Our 2Q19 drug pipeline Data Page includes @Novartis's #Piqray (alpelisib), the first new drug application for a new mol…
2019 2Qパイプライン https://t.co/jY1xq4kTGX https://t.co/JHp4cXICsj
Our 2Q19 drug pipeline Data Page includes @Novartis's #Piqray (alpelisib), the first new drug application for a new molecular entity approved under the @US_FDA Real-Time Oncology Review pilot program, which aims to speed approvals while ensuring safety ht